An extraordinary series of discoveries about chronic myeloid leukemia (CML) has made this
disease a model of the way in which bench and bedside research can unite and culminate …

Although it is now generally accepted that imatinib is the best initial treatment for patients
newly diagnosed with chronic myeloid leukemia (CML) in chronic phase, a number of …

This study reports outcomes of allogeneic hematopoietic stem cell transplantation with
reduced-intensity conditioning (RIC) in 186 patients with chronic myeloid leukemia (CML) …

Allogeneic hematopoietic cell transplantation (HCT) following nonmyeloablative
conditioning has been extensively evaluated in patients with hematologic malignancies who …

The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem
cell transplantation (SCT) is controversial. We monitored chimerism status by short tandem …

Allogeneic hematopoietic stem cell transplantation (ASCT) is a well‐established therapy for
leukemias and other immunohematopoietic disorders. In more recent years, bone marrow as …

Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation
(HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and …

Chronic myeloid leukemia provides an illustrative disease model for both molecular
pathogenesis of cancer and rational drug therapy. Chronic myeloid leukemia is a clonal …

We evaluated retrospectively the incidence of acute kidney injury (AKI), defined by risk,
injury, failure, loss and end-stage kidney disease (RIFLE) and its influence on long-term …

OBJECTIVE: With the introduction of non-myeloablative hematopoietic cell transplantation,
acute graft-versus-host-disease (GvHD) is frequently observed beyond the traditional 100 …